EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Updates in the pathogenesis of SJS/TEN

Joy Justice, Eric Mukherjee, Michelle Martin-Pozo, Elizabeth Phillips

Allergology International · 2025-07 · 74 (3) · 361-371

DOI: 10.1016/j.alit.2025.05.002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Allergology International, 2025-07. Verfasst von Joy Justice und 3 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt University School of Medicine, Nashville, TN, USA. Hauptthemen laut MEDLINE: Stevens-Johnson Syndrome. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAMS NIH HHS, NHGRI NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe cutaneous adverse reactions across a spectrum of severity characterized by widespread epidermal detachment and keratinocyte apoptosis. SJS/TEN develops due to a complex immunologic response after exposure to an associated drug antigen and/or its metabolite, and it results in significant morbidity and mortality. Complex immune mechanisms contribute to keratinocyte death. Drug-induced SJS/TEN has been shown to be strongly HLA class I restricted which has contributed to our understanding of mechanisms and has the potential to shape prevention and diagnosis. There is currently no evidence-based treatment outside of aggressive supportive care, and understanding the complete immunopathogenesis of SJS/TEN will be key for the development of efficacious and safe treatments that significantly reduce morbidity and mortality. This article focuses on what is new in the pathogenesis of SJS/TEN, including recent research on the mechanisms of T-cell activation, apoptotic and necroptotic mediators, other related molecules, genetic associations, and possible targeted treatment options.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stevens-Johnson SyndromeHumansApoptosisAnimalsT-LymphocytesKeratinocytesLymphocyte Activation

Stichwörter der Autor:innen

CytotoxicHLA antigensStevens-Johnson syndromeT-lymphocytesToxic epidermal necrolysis

Autor:innen und Institutionen

  • Vanderbilt University School of Medicine, Nashville, TN, USA.
  • Vanderbilt University Medical Center, Department of Dermatology, Nashville, TN, USA; Vanderbilt University Medical Center, Center for Drug Safety and Immunology, Nashville, TN, USA.
  • Vanderbilt University Medical Center, Center for Drug Safety and Immunology, Nashville, TN, USA.
  • Vanderbilt University Medical Center, Department of Pathology, Microbiology, and Immunology, Nashville, TN, USA. Electronic address: elizabeth.j.phillips@vumc.org.

Förderung

  • NIAMS NIH HHS
  • NHGRI NIH HHS
  • NIAID NIH HHS
  • National Health and Medical Research Council
  • NIH NIAID
  • National Institutes of Health

Zitieren

APA

Justice, J., Mukherjee, E., Martin-Pozo, M., & Phillips, E. (2025). Updates in the pathogenesis of SJS/TEN. Allergology International, 74(3), 361-371. https://doi.org/10.1016/j.alit.2025.05.002

Vancouver

Justice J, Mukherjee E, Martin-Pozo M, Phillips E. Updates in the pathogenesis of SJS/TEN. Allergology International. 2025;74(3):361-371. doi:10.1016/j.alit.2025.05.002

BibTeX
@article{Justice2025,
  author = {Justice, Joy and Mukherjee, Eric and Martin-Pozo, Michelle and Phillips, Elizabeth},
  title = {Updates in the pathogenesis of SJS/TEN},
  journal = {Allergology International},
  year = {2025},
  volume = {74},
  number = {3},
  pages = {361--371},
  doi = {10.1016/j.alit.2025.05.002}
}
Kostenlos starten →